We only have this paper's title and publication details.
Read it at the sourceRandomized controlled trial will evaluate placebo and nocebo effects on diarrhea-predominant irritable bowel syndrome, suggesting insights into Chinese medicine efficacy.
Chinese Clinical Trial Registry (ChiCTR2300067549), registered on 11 January 2023.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: